UC’s May 2 wine & spirits tasting: Rosé All Day

Make your reservations now to enjoy wines that are light and springy, paired with fresh, complementary appetizers

Menu

Rosé All Day, featuring Chef Nicole Guenther:

  • Belleruche Rosépaired with crostini with prosciutto and garlic herbed ricotta cheese
  • Sunseeker Rosépaired with brown sugar and balsamic glazed chicken, seared halibut with lemon and capers, sides: rosemary scalloped potatoes and panko parmesan roasted broccoli
  • Il Poggione Rosé Brancatopaired with triple berry tiramisu with lemon whipped topping

 

To RSVP

Please call 513-556-3135, or email mick_macks@uc.edu. More beverage selections available. Must be 21 or older and present valid ID to buy and consume alcohol.

Save the Dates

UC wine & spirits tastings take place every first Thursday, and chef’s tables every third Thursday.

  • Thursday, May 16 for chef's table, a chef-inspired, three-course meal featuring fresh seasonal ingredients with beverage pairings, served at 5:30 p.m.
  • Thursday, June 6 for wine & spirits tasting, three distinct wines paired with complementary courses, served at 5:30 p.m.

And think about reserving Mick & Mack’s for your next event!

 

Tangeman University Center, Level 3
uc.edu/food/mick-and-macks

 

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.